Change takes time – in all fields, including surgery. Yet, innovation is highly prized. The latest tools and technologies are celebrated and heavily invested in. But not all improvements require new technology.
For example, robotic pancreatic surgery is being adopted worldwide at a cost of millions in capital investment and ongoing expenses. Evidence shows it is mostly non-inferior to the standard of care.1–4 Another example is histotripsy for liver tumors, which has been rapidly purchased across multiple centers since FDA approval in 2023, spreading like mushrooms after the rain. Evidence is limited to technical feasibility, with no proof of superiority over standard care.5 Both technologies are used only in selected patients. By contrast, high-volume anesthesiology care for hepato-pancreato-biliary (HPB) surgery is associated with15% lower odds of 90-day major morbidity (OR 0.85, 95% CI 0.76–0.94), requires no capital investment, no recurring costs, and applies to all patients.
We are not debating or questioning the benefits of these technologies or the need to invest in new treatments. Rather, we would like to ask: if we are so willing to spend vast sums on new technology, why are we far less inclined to redesign how operative teams are organized?
Operative teams and volume-outcomes
For decades, the optimization of surgical outcomes in HPB surgery has been linked to higher case volumes. Complex HPB surgery has been organized in high-volume centres and requirements for minimum number of procedures have been set for surgeons.6–17 But one critical member of the perioperative team has been largely overlooked: the anesthesiologist. Our research has reported that care by anesthesiologists with higher HPB volume is associated with reduced major morbidity, even after adjusting for surgeon and hospital volume.18–20
So why not create specialized HPB anesthesiology teams?
Unintended consequences?
Some worry that concentrating anesthesiologists in HPB work will erode their exposure to other surgical areas, potentially limiting skills for emergencies or elective cases in other specialties. We examined the relationship between HPB case volume and non-HPB surgical volume in a study published in the BJS.
21
The results? Higher HPB volume was not associated with a meaningful drop in other cases. In absolute terms, high-volume HPB anesthesiologists often did more non-HPB work – potentially because they worked more days. When adjusting for total days worked, there was a 0.5% reduction in the rate of non-HPB surgery per additional HPB case, a statistically significant but likely clinically trivial difference. In other words, you could have higher HPB anesthesiology volume without sacrificing exposure to other types of surgery.
Team organization for better care delivery?
The efficiency and quality of care can often be improved more by delivering the current standard of care consistently than by developing new, and often costly, treatments or devices.22 Team organization is a cornerstone of reliable and high-quality care delivery. Our research has shown that not only does an anesthesiologist’s clinical volume matter, but so do the familiarity between anesthesiologists and surgeons and the diversity of the anesthesiology-surgery team.23,24 Consistent teams and more diverse teams can deliver better outcomes. These are structural factors, embedded in how the OR team is organized, that influence patient outcomes.
Re-organizing anesthesiology care to increase provider volume is a structural change. It’s a low- or no-cost intervention that can be implemented within existing resources. It would seem far cheaper than the billions spent on purchasing cutting-edge devices. But unlike high-profile technology launches, team reorganization is not “flashy” and rarely makes headlines or marketing and donor campaigns. Workflow and culture changes can also be daunting, possibly more so than adopting new technology. They can be perceived as threatening or disruptive.
If this is such a clear opportunity, why hasn’t it happened yet?
Likely because it challenges a deeply ingrained model that has evolved from a mix of system, hospital, and physician-level factors. At the system level, growing service demands and a shrinking per-capita anesthesiologist workforce have made flexible scheduling a necessity. At the hospital level, assignments are often designed to balance diverse expertise across many clinical areas, respond to call schedules demands, and manage operating room efficiency. At the individual level, preferences may be influenced by case familiarity, length of the work-day, or physician remuneration models. Addressing these challenges requires confronting long-standing norms, aligning incentives, and working collaboratively across multiple stakeholder groups to redesign call structures, room assignments, and career pathways, with the goal of ensuring anesthesiologists in specialized centres maintain a minimum volume of HPB cases.
We’re not advocating for blunt-force HPB anesthesiology specialization without safeguards. We must anticipate and understand potential unintended consequences for the health system, its physicians, and the patients it serves. That’s why our ongoing work now focuses on examining potential unintended consequences. We’re conducting environmental scans, exploring different organizational models, and engaging clinicians to understand their perspectives.
Ultimately, the operating room isn’t just a collection of skilled individuals – it’s a system. And systems can be designed to optimize performance.
If we have accepted that surgeon and hospital volumes matter and have organized entire systems around it, why would we still accept random allocation of anesthesiologists to some of our highest-risk cases?
If outcomes can be improved through a no-cost, structural innovation that works within existing resources, could we justify not doing it?
References
Menso JE, Francken MFG, de Graaf N, Bonomi AM, Guastella R, Balaban D, et al. Cost-analysis of Implementing robot-assisted Versus Open Pancreatoduodenectomy. Ann Surg [Internet]. Ann Surg; 2025 Feb 10 [cited 2025 Aug 14]; Available from: http://dx.doi.org/10.1097/SLA.0000000000006665
Korrel M, Jones LR, van Hilst J, Balzano G, Björnsson B, Boggi U, et al. Minimally invasive versus open distal pancreatectomy for resectable pancreatic cancer (DIPLOMA): an international randomised non-inferiority trial. Lancet Reg Health Eur. Elsevier; 2023 Aug 1; 31: 100673.
Emmen AMLH, de Graaf N, Ramera M, Busch OR, Luyer MD, Mieog JSD, et al. Minimally invasive versus open pancreatoduodenectomy for pancreatic and periampullary neoplasm (DIPLOMA-2): an international patient-blinded randomized trial. HPB (Oxford). Elsevier BV; 2024 Jan 1; 26: S42–S43.
Klotz R, Mihaljevic AL, Kulu Y, Sander A, Klose C, Behnisch R, et al. Robotic versus open partial pancreatoduodenectomy (EUROPA): a randomised controlled stage 2b trial. Lancet Reg Health Eur. Elsevier BV; 2024 Apr 1; 39: 100864.
Mendiratta-Lala M, Wiggermann P, Pech M, Serres-Créixams X, White SB, Davis C, et al. The #HOPE4LIVER single-arm pivotal trial for histotripsy of primary and metastatic liver tumors. Radiology. Radiological Society of North America (RSNA); 2024 Sep; 312: e233051.
Birkmeyer JD, Stukel TA, Siewers AE, Goodney PP, Wennberg DE, Lucas FL. Surgeon volume and operative mortality in the United States. N Engl J Med. 2003; 349: 2117 2127.
Finks JF, Osborne NH, Birkmeyer JD. Trends in hospital volume and operative mortality for high-risk surgery. N Engl J Med. 2011 Jun 2; 364: 2128–2137.
Bilimoria KY, Bentrem DJ, Feinglass JM, Stewart AK, Winchester DP, Talamonti MS, et al. Directing surgical quality improvement initiatives: comparison of perioperative mortality and long-term survival for cancer surgery. J Clin Oncol. 2008; 26: 4626 4633.
Funk LM, Gawande AA, Semel ME, Lipsitz SR, Berry WR, Zinner MJ, et al. Esophagectomy outcomes at low-volume hospitals: the association between systems characteristics and mortality. Ann Surg. 2011 May; 253: 912–917.
Johnston MJ, Singh P, Pucher PH, Fitzgerald JEF, Aggarwal R, Arora S, et al. Systematic review with meta-analysis of the impact of surgical fellowship training on patient outcomes. Br J Surg. 2015 Sep; 102: 1156–1166.
Ely S, Alabaster A, Ashiku SK, Patel A, Velotta JB. Regionalization of thoracic surgery improves short-term cancer esophagectomy outcomes. J Thorac Dis. 2019 May; 11: 1867–1878.
Simunovic M, Urbach D, Major D, Sutradhar R, Baxter N, To T, et al. Assessing the volume-outcome hypothesis and region-level quality improvement interventions: pancreas cancer surgery in two Canadian Provinces. Ann Surg Oncol. 2010 Oct; 17: 2537–2544.
Gasper WJ, Glidden DV, Jin C, Way LW, Patti MG. Has recognition of the relationship between mortality rates and hospital volume for major cancer surgery in California made a difference?: A follow-up analysis of another decade. Ann Surg. 2009; 250: 472 483.
Allgood PC, Bachmann MO. Effects of specialisation on treatment and outcomes in screen-detected breast cancers in Wales: cohort study. Br J Cancer. 2006 Jan 16; 94: 36–42.
Swan RZ, Niemeyer DJ, Seshadri RM, Thompson KJ, Walters A, Martinie JB, et al. The impact of regionalization of pancreaticoduodenectomy for pancreatic Cancer in North Carolina since 2004. Am Surg. 2014 Jun; 80: 561–566.
Surgical Volume [Internet]. 2018 [cited 2020 Jul 17]. Available from: https://www.leapfroggroup.org/ratings-reports/surgical-volume
Designated Cancer Surgery Centres [Internet]. 2017 [cited 2020 Jul 18]. Available from: https://www.cancercareontario.ca/en/find-cancer-services/designated-cancer-surgery-centres
Hallet J, Jerath A, Turgeon AF, McIsaac DI, Eskander A, Zuckerman J, et al. Association Between Anesthesiologist Volume and Short-term Outcomes in Complex Gastrointestinal Cancer Surgery. JAMA Surg. 2021 May 1; 156: 479–487.
Hallet J, Sutradhar R, Eskander A, Carrier FM, McIsaac D, Turgeon AF, et al. Variation in Anesthesiology Provider-Volume for Complex Gastrointestinal Cancer Surgery: A Population-Based Study. Ann Surg. 2023 Oct 1; 278: e820–e826.
Hallet J, Jerath A, Perez d’Empaire P, Eskander A, Carrier FM, McIsaac DI, et al. The Association between Hospital High-volume Anesthesiology Care and Patient Outcomes for Complex Gastrointestinal Cancer Surgery: A Population-based Study. Ann Surg. 2023; 278: e503–e510.
Hallet J, Acher AW, Jivraj N, McIsaac DI, Carrier FM, Turgeon AF, Flexman A, Lorello G, Chan WC, Gombay A, Ding A, Armah J, Eskander A, Sutradhar R. Association of anesthesiologists’ hepato-pancreato-biliary volume with volume of other surgeries. Br J Surg. 2025; doi: doi.org/10.1093/bjs/znaf192
Woolf SH, Johnson RE. The break-even point: when medical advances are less important than improving the fidelity with which they are delivered. Ann Fam Med. Annals of Family Medicine; 2005 Nov; 3: 545–552.
Hallet J, Jerath A, d’Empaire PP, Carrier FM, Turgeon AF, McIsaac DI, et al. Familiarity of the surgeon-anesthesiologist dyad and major morbidity after high-risk elective surgery. JAMA Surg. American Medical Association (AMA); 2025. p. 772–781.
Hallet J, Sutradhar R, Jerath A, d’Empaire PP, Carrier FM, Turgeon AF, et al. Association between familiarity of the surgeon-anesthesiologist dyad and postoperative patient outcomes for complex gastrointestinal cancer surgery. JAMA Surg. 2023 May 1; 158: 465–473.






.png)





.jpg)




